OBJECTIVES: To determine the genetic contribution to non-autosomal dominant early-onset Alzheimer disease (EOAD) (onset age ≤60 years) cases and identify the likely mechanism of inheritance in those cases. DESIGN: A liability threshold model of disease was used to estimate heritability of EOAD and late-onset Alzheimer disease (AD) using concordance for AD among parent-offspring pairs. SETTING: The Uniform Data Set, whose participants were collected from 32 US Alzheimer's Disease Centers, maintained by the National Alzheimer's Coordinating Center. PARTICIPANTS: Individuals with probable AD and detailed parental history (n = 5370). MAIN OUTCOME MEASURES: The concordance among relatives and heritability of EOAD and late-onset AD. RESULTS: For late-onset AD (n = 4302), we found sex-specific parent-offspring concordance that ranged from approximately 10% to 30%, resulting in a heritability of 69.8% (95% confidence interval, 64.6%-75.0%), and equal heritability for both sexes regardless of parental sex. For EOAD (n = 702), we found that the parent-offspring concordance was 10% or less and concordance among siblings was 21.6%. Early-onset AD heritability was 92% to 100% for all likely values of EOAD prevalence. CONCLUSIONS: We confirm late-onset AD is a highly polygenic disease. By contrast, the data for EOAD suggest it is an almost entirely genetically based disease, and the patterns of observed concordance for parent-offspring pairs and among siblings lead us to reject the hypotheses that EOAD is a purely dominant, mitochondrial, X-linked, or polygenic disorder. The most likely explanation of the data is that approximately 90% of EOAD cases are due to autosomal recessive causes.
OBJECTIVES: To determine the genetic contribution to non-autosomal dominant early-onset Alzheimer disease (EOAD) (onset age ≤60 years) cases and identify the likely mechanism of inheritance in those cases. DESIGN: A liability threshold model of disease was used to estimate heritability of EOAD and late-onset Alzheimer disease (AD) using concordance for AD among parent-offspring pairs. SETTING: The Uniform Data Set, whose participants were collected from 32 US Alzheimer's Disease Centers, maintained by the National Alzheimer's Coordinating Center. PARTICIPANTS: Individuals with probable AD and detailed parental history (n = 5370). MAIN OUTCOME MEASURES: The concordance among relatives and heritability of EOAD and late-onset AD. RESULTS: For late-onset AD (n = 4302), we found sex-specific parent-offspring concordance that ranged from approximately 10% to 30%, resulting in a heritability of 69.8% (95% confidence interval, 64.6%-75.0%), and equal heritability for both sexes regardless of parental sex. For EOAD (n = 702), we found that the parent-offspring concordance was 10% or less and concordance among siblings was 21.6%. Early-onset AD heritability was 92% to 100% for all likely values of EOAD prevalence. CONCLUSIONS: We confirm late-onset AD is a highly polygenic disease. By contrast, the data for EOAD suggest it is an almost entirely genetically based disease, and the patterns of observed concordance for parent-offspring pairs and among siblings lead us to reject the hypotheses that EOAD is a purely dominant, mitochondrial, X-linked, or polygenic disorder. The most likely explanation of the data is that approximately 90% of EOAD cases are due to autosomal recessive causes.
Authors: L A Farrer; R H Myers; L A Cupples; P H St George-Hyslop; T D Bird; M N Rossor; M J Mullan; R Polinsky; L Nee; L Heston Journal: Neurology Date: 1990-03 Impact factor: 9.910
Authors: D A Evans; H H Funkenstein; M S Albert; P A Scherr; N R Cook; M J Chown; L E Hebert; C H Hennekens; J O Taylor Journal: JAMA Date: 1989-11-10 Impact factor: 56.272
Authors: Annette L Fitzpatrick; Lewis H Kuller; Diane G Ives; Oscar L Lopez; William Jagust; John C S Breitner; Beverly Jones; Constantine Lyketsos; Corinne Dulberg Journal: J Am Geriatr Soc Date: 2004-02 Impact factor: 5.562
Authors: D L Bachman; P A Wolf; R Linn; J E Knoefel; J Cobb; A Belanger; R B D'Agostino; L R White Journal: Neurology Date: 1992-01 Impact factor: 9.910
Authors: C M van Duijn; P de Knijff; M Cruts; A Wehnert; L M Havekes; A Hofman; C Van Broeckhoven Journal: Nat Genet Date: 1994-05 Impact factor: 38.330
Authors: J C Breitner; K A Welsh; B A Gau; W M McDonald; D C Steffens; A M Saunders; K M Magruder; M J Helms; B L Plassman; M F Folstein Journal: Arch Neurol Date: 1995-08
Authors: Thomas S Wingo; David J Cutler; Aliza P Wingo; Ngoc-Anh Le; Gil D Rabinovici; Bruce L Miller; James J Lah; Allan I Levey Journal: JAMA Neurol Date: 2019-07-01 Impact factor: 18.302
Authors: Brian W Kunkle; Badri N Vardarajan; Adam C Naj; Patrice L Whitehead; Sophie Rolati; Susan Slifer; Regina M Carney; Michael L Cuccaro; Jeffery M Vance; John R Gilbert; Li-San Wang; Lindsay A Farrer; Christiane Reitz; Jonathan L Haines; Gary W Beecham; Eden R Martin; Gerard D Schellenberg; Richard P Mayeux; Margaret A Pericak-Vance Journal: JAMA Neurol Date: 2017-09-01 Impact factor: 18.302
Authors: Agustín Ruiz; Isabel Hernández; Maiteé Ronsende-Roca; Antonio González-Pérez; Emma Rodriguez-Noriega; Reposo Ramírez-Lorca; Ana Mauleón; Concha Moreno-Rey; Lucie Boswell; Larry Tune; Sergi Valero; Montserrat Alegret; Javier Gayán; James T Becker; Luis Miguel Real; Lluís Tárraga; Clive Ballard; Michael Terrin; Stephanie Sherman; Haydeh Payami; Oscar L López; Jacobo E Mintzer; Mercè Boada Journal: Neurobiol Aging Date: 2012-10-01 Impact factor: 4.673
Authors: Alison I Bernstein; Yunting Lin; R Craig Street; Li Lin; Qing Dai; Li Yu; Han Bao; Marla Gearing; James J Lah; Peter T Nelson; Chuan He; Allan I Levey; Jennifer G Mullé; Ranhui Duan; Peng Jin Journal: Hum Mol Genet Date: 2016-04-09 Impact factor: 6.150